House Bill 6143
115th Congress(2017-2018)
Patient Right to Know Drug Prices Act
Introduced
Introduced in House on Jun 19, 2018
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
6143
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Lloyd Doggett
grade
Texas
Arizona
Arizona
California
California
California
California
California
California
California
District of Columbia
Georgia
Illinois
Maryland
Maryland
Maryland
Michigan
Minnesota
Mississippi
Missouri
Nevada
New Hampshire
New York
New York
Oregon
Rhode Island
Tennessee
Texas
Texas
Washington
Wisconsin
Wisconsin
No House votes have been held for this bill.
Summary
Patient Right to Know Drug Prices Act
This bill prohibits a health insurance plan or pharmacy benefits manager from restricting a pharmacy from informing an enrollee of any difference between the cost of a drug under the plan and the cost of the drug without health insurance coverage. (Such restrictions are commonly referred to as gag clauses.)
June 19, 2018
06/19/2018
Referred to the House Committee on Energy and Commerce.
06/19/2018
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:42:20 PM